You may also like

Versant-Backed Nexo Gets $60M to Pursue Tough Cancer Targets
Startup Profiles: Upstream Bio Gets Another $200M, Kate Therapeutics Debuts with $51M
Abdera Gets $142M To Make Potent, Safe, Radioantibodies for Cancer
Belharra Gets $130M from Versant, Genentech For Chemoproteomic Discovery